Empower Pharmacy, a Houston-based compounding pharmacy targeting integrated health and wellness, is seeking an investment, sources tell Axios.
Why it matters: Private equity has a reputation for being acquisitive in compounding pharmacy — and Empower's growth profile and attractive end-markets suggest the asset will likely draw strong interest.
Driving the news: The founder-run company has mandated Cantor Fitzgerald for financial advice, with outreach to financial sponsors kicking off early this week, sources say.
By the numbers: The company, growing at a more than 30% clip over the last three years, is marketing close to $160 million of run-rate revenue off of EBITDA in the low $30 million range, sources say.
Details: Empower is seeking capital to fund the development of a new 503B facility that will substantially increase its growth trajectory and capacity over the next decade, one source says.
How it works: Empower, founded in 2009 by CEO Shaun Noorian, provides compounding pharmacy solutions for various health and wellness end-markets.
State of play: Empower is unique in its end-market focus areas, but private equity participation in the compounding pharmacy arena isn't new. In notable activity…
💭 Our thought bubble: Considering Bain's seven-year plus hold, QuVa also looks ripe for potential picking.
Empower did not immediately return a request for comment, while Cantor declined to comment.

source